RALOXIFENE SKELETAL EFFECTS ARE IMPROVED WITH WEEKLY TERIPARATIDE [RHPTH (1-34)] IN OSTEOPENIC OVARIACTOMIZED RATS

被引:0
|
作者
Ma, Y. L. [1 ]
Schmidt, A. [1 ]
Zeng, Q. Q. [1 ]
Zhang, Q. [2 ]
Jee, W. S. [2 ]
Sato, M. [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Univ Utah, Div Radiobiol, Salt Lake City, UT 84112 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:S83 / S83
页数:1
相关论文
共 50 条
  • [1] Low dose teriparatide [RHPTH (1-34)] is more efficacious than strontium ranelate in osteopenic ovariactomized rats
    Ma, Y. L.
    Zeng, Q.
    Schmidt, A.
    Porras, L.
    Adrian, M. D.
    Harvey, A.
    Shelbourn, T. L.
    Wronski, T.
    Iturria, S. J.
    Bryant, H. U.
    Sato, M.
    [J]. BONE, 2009, 44 (02) : S450 - S450
  • [2] Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats
    Yanfei L. Ma
    Henry U. Bryant
    Qingqiang Zeng
    Allen Schmidt
    Webster S. S. Jee
    Masahiko Sato
    [J]. Journal of Bone and Mineral Metabolism, 2005, 23 : 62 - 68
  • [3] Raloxifene and teriparatide (hPTH 1-34) have complementary effects on the osteopenic skeleton of ovariectomized rats
    Ma, YFL
    Bryant, HU
    Zeng, QQ
    Schmidt, A
    Jee, WSS
    Sato, M
    [J]. JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (Suppl 1) : 62 - 68
  • [4] Raloxifene improves the skeletal efficacy of teriparatide [RHPTH (1-34), TPTD] at clinically relevant doses
    Sato, M
    Schmidt, A
    Smith, S
    Ma, LY
    [J]. BONE, 2003, 32 (05) : S211 - S212
  • [5] Teriparatide (rhPTH (1-34)) skeletal efficacy is not affected by longterm pretreatment with alendronate, estrogen, or raloxifene in ovariectomized rats.
    Ma, YL
    Zeng, QQ
    Schmidt, A
    Hoover, JL
    Cole, HW
    Bryant, HU
    Sato, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S167 - S167
  • [6] Teriparatide [rhPTH (1-34)], But Not Strontium Ranelate, Demonstrated Bone Anabolic Efficacy in Mature, Osteopenic, Ovariectomized Rats
    Ma, Yanfei L.
    Zeng, Qing Q.
    Porras, Leah L.
    Harvey, Anita
    Moore, Terry L.
    Shelbourn, Timothy L.
    Dalsky, Gail P.
    Wronski, Thomas J.
    Aguirre, J. Ignacio
    Bryant, Henry U.
    Sato, Masahiko
    [J]. ENDOCRINOLOGY, 2011, 152 (05) : 1767 - 1778
  • [7] Teriparatide (rhPTH(1-34) improves the structural geometry of the hip
    Uusi-Rasi, K
    Beck, TJ
    Oreskovic, TL
    Sato, M
    Boado, CE
    Zanchetta, JR
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S208 - S208
  • [8] Bisphosphonates affect signaling pathways utilized by teriparatide [rhPTH(1-34)].
    Sun, Q
    Katz, RW
    Morris, SA
    Bilezikian, JP
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S230 - S231
  • [9] Effects of Intravenous Zoledronic Acid Plus Subcutaneous Teriparatide [rhPTH(1-34)] in Postmenopausal Osteoporosis
    Cosman, Felicia
    Eriksen, Erik Fink
    Recknor, Chris
    Miller, Paul D.
    Guanabens, Nuria
    Kasperk, Christian
    Papanastasiou, Philemon
    Readie, Aimee
    Rao, Hanumantha
    Gasser, Juerg A.
    Bucci-Rechtweg, Christina
    Boonen, Steven
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (03) : 503 - 511
  • [10] Comparative analysis of the cost-effectiveness of teriparatide [RHPTH(1-34)] versus RHPTH(1-84)
    Borgstroem, F.
    Stroem, O.
    Kutahov, A.
    Marin, F.
    Ljunggren, O.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A396 - A396